Nicolas Wentzensen to Lead New Clinical Epidemiology Group
, by DCEG Staff
Nicolas Wentzensen
Nicolas Wentzensen, M.D., Ph.D., has been appointed Deputy Chief and lead of a new clinical epidemiology group in the Clinical Genetics Branch (CGB). The new group will expand on CGB’s expertise and success in patient-centered studies, cancer screening, and translational epidemiology to address the spectrum of cancer risk in more diverse populations.
Dr. Wentzensen joined DCEG as a visiting fellow in 2007, became a tenure-track investigator in 2009, and was awarded scientific tenure by NIH and appointed senior investigator in 2013. He has received international recognition for his research on etiologic heterogeneity and biomarker discovery of gynecological cancers, mainly cervical and ovarian. Dr. Wentzensen earned an M.D. and a Ph.D. in applied tumor biology from the University of Heidelberg. He also received a Master of Epidemiology from the University of Mainz.